Use of inhaled corticosteroids in bronchiectasis: data from the European Bronchiectasis Registry (EMBARC)

202516 citationsJournal Articlehybrid Open Access

Authors

Jennifer S. Pollock · University of Dundee

Eva Polverino · Vall d'Hebron Hospital Universitari

Raja Dhar · Sujata Birla Hospital and Medical Research Center

Katerina Dimakou · Sotiria General Hospital

Letizia Traversi · Vall d'Hebron Hospital Universitari

Apostolos Bossios · Karolinska University Hospital

Charles Haworth

Abstract

ICS use is common in bronchiectasis, including in those not currently recommended ICS according to bronchiectasis guidelines. ICS use may be associated with reduced exacerbation frequency in patients with elevated blood eosinophils.

Topics & Keywords

Cystic Fibrosis Research Advances Neonatal Respiratory Health Research Tracheal and airway disorders

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Thorax

Volume 80, Issue 6, pp. 358-368

DOI: 10.1136/thorax-2024-221825

Field-Weighted Citation Impact: 23.72